Department of Stomatology, The First People's Hospital of Fuyang Hangzhou, Hangzhou, Zhejiang, China.
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820971306. doi: 10.1177/1533033820971306.
In the present study, we aimed to find an effective target for the treatment of tongue cancer using gene chip screening and signal pathway research.
We used microarray screening and gene expression profile analyses to find important differentially expressed genes in tongue cancer. We constructed a protein-protein interaction network, and used enrichment analysis of the Kyoto Encyclopedia of Genes and Genomes to screen for important genes. We then silenced the genes of interest in SCC154 cells to study the relationship with the Phosphatidylinositol 3-kinase/Akt signal pathway. Western blot analyses, the 3-(4,5Dimethylthiazol-yl)-2,5Dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) test, and immunofluorescence assays were used to compare the expression levels of Phosphatidylinositol 3-kinase/Akt signal pathway-related proteins, cell viability, and cell proliferation ability in normal SCC154 cells, Si-RNA SCC154 cells, and gene-silenced SCC154 cells. The scratch test, Transwell test, and western blotting were used to determine migration, invasion, and carcinogenesis.
Using GSE9844, GSE13601, and GSE31056 gene chips, we identified 93 upregulated genes and 76 downregulated genes in tongue cancer. Using the protein-protein interaction network and Kyoto Encyclopedia of Genes and Genomes enrichment analyses, we further identified 47 differentially expressed genes. Using Kaplan-Meier plotter online tools, we also identified 3 genes (SPP1, Recombinant Human Secreted Phosphoprotein 1; PLAU, plasminogen activator urinary; and APP, amyloid precursor protein). Compared with normal SCC154 cells and Si-RNA control SCC154 cells, the expressions of Phosphatidylinositol 3-kinase/Akt pathway proteins in si-SPP1 SCC154 cells were significantly decreased (*P < 0.05), and the protein activities and proliferation abilities were also significantly decreased (*P < 0.05), while the migration ability, invasion ability, and cancer forming ability were significantly increased (*P < 0.05).
Inhibition of the SPP1 gene may have a therapeutic effect on tongue cancer, and could be an effective target for the treatment of this disorder.
在本研究中,我们旨在通过基因芯片筛选和信号通路研究,找到治疗舌癌的有效靶点。
我们使用微阵列筛选和基因表达谱分析来发现舌癌中重要的差异表达基因。我们构建了蛋白质-蛋白质相互作用网络,并使用京都基因与基因组百科全书富集分析筛选重要基因。然后,我们在 SCC154 细胞中沉默感兴趣的基因,以研究其与磷脂酰肌醇 3-激酶/蛋白激酶 B 信号通路的关系。Western blot 分析、3-(4,5-二甲基噻唑-2)-2,5-二甲基噻唑-2-yl)-2,5-二苯基四氮唑溴盐(MTT)试验和免疫荧光分析用于比较正常 SCC154 细胞、Si-RNA SCC154 细胞和基因沉默 SCC154 细胞中磷脂酰肌醇 3-激酶/蛋白激酶 B 信号通路相关蛋白的表达水平、细胞活力和细胞增殖能力。划痕试验、Transwell 试验和 Western blot 用于测定迁移、侵袭和癌变。
使用 GSE9844、GSE13601 和 GSE31056 基因芯片,我们在舌癌中鉴定出 93 个上调基因和 76 个下调基因。使用蛋白质-蛋白质相互作用网络和京都基因与基因组百科全书富集分析,我们进一步鉴定出 47 个差异表达基因。使用 Kaplan-Meier plotter 在线工具,我们还鉴定出 3 个基因(SPP1、尿激肽原酶和 APP)。与正常 SCC154 细胞和 Si-RNA 对照 SCC154 细胞相比,si-SPP1 SCC154 细胞中磷脂酰肌醇 3-激酶/蛋白激酶 B 通路蛋白的表达明显降低(*P < 0.05),蛋白活性和增殖能力也明显降低(*P < 0.05),而迁移能力、侵袭能力和癌变能力明显增强(*P < 0.05)。
抑制 SPP1 基因可能对舌癌有治疗作用,可作为治疗该疾病的有效靶点。